Fortum | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Fortum

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 18 USDMF, 16 CEP/COS, 6 JDMF, 4 EU WC, 4 KDMF, 4 NDC API, 14 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

6 Intermediates Suppliers

6 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

221 FDF Dossiers, 42 FDA Orange Book, 100 Europe, 6 Canada, 16 South Africa, 57 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 20MG BASE/ML, INJECTABLE;INJECTION - EQ 40MG BASE/ML, INJECTABLE;INJECTION - EQ 1GM BASE, INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Fillers, Diluents & Binders, 1 Co-Processed Excipients, 1 Taste Masking

DIGITAL CONTENT

4 DATA COMPILATION #PharmaFlow, 25 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 82 Finished Drug Prices, 8 Annual Reports

MARKET PLACE

20 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 4 US Exclusivities, 16 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 4 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

8 All

01 4Avycaz

02 4Zavicefta

List of Suppliers

Product Main Page

01

Brand Name : Avycaz

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ceftazidime and Avibactam

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 61

2016 Revenue in Millions : 36

Growth (%) : 69

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Avycaz

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ceftazidime And Avibactam

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 95

2017 Revenue in Millions : 61

Growth (%) : 55%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Avycaz

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ceftazidime

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 117

2018 Revenue in Millions : 95

Growth (%) : 23

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Avycaz

CPhI India 2024

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Ceftazidime And Avibactam

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 36

2015 Revenue in Millions : 23

Growth (%) : 57

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Zavicefta

CPhI India 2024

Not Confirmed

06

Brand Name : Zavicefta

CPhI India 2024

Not Confirmed

07

Brand Name : Zavicefta

CPhI India 2024

Not Confirmed

08

Brand Name : Zavicefta

CPhI India 2024

Not Confirmed

Contact us
to update this info